Challenges in developing and using biomarkers include ensuring their accuracy, sensitivity, and specificity, as well as their validation and standardization across different populations. Additionally, the high costs and time involved in development, ethical considerations, and the need for regulatory approvals pose significant hurdles. Integration into clinical workflow also requires extensive training and education.